Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
AIDS Research and Human Retroviruses|September 7, 2023
The Association of HIV-Specific Risk Factors with Cardiovascular Events in Addition to Traditional Risk Factors in People Living with HIVLaven Mavarani, Nico Reinsch, Sarah Albayrak-Rena, et al.BMC Infectious Diseases|February 9, 2020
STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in GermanyKlaus Jansen, Gyde Steffen, Anja Potthoff, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trialSarah Heinze, Friederike Egberts, Susanne Rötzer, et al.Frontiers in Molecular Biosciences|January 19, 2016
Characterization of the Olfactory Receptors Expressed in Human SpermatozoaCaroline Flegel, Felix Vogel, Adrian Hofreuter, et al.BMC Public Health|December 12, 2025
HPV knowledge and acceptance of HPV vaccination among men who have sex with men (MSM) in Germany: a multicenter, observational, cross-sectional studyCornelia Wähner, Lisa M Lang, Maher Almahfoud, et al.Infection|August 5, 2017
Prolongation of the QTc interval in HIV-infected individuals compared to the general populationNico Reinsch, Marina Arendt, Marie Henrike Geisel, et al.Nature Microbiology|November 14, 2018
Centrosomal protein TRIM43 restricts herpesvirus infection by regulating nuclear lamina integrityFlorian Full, Michiel van Gent, Konstantin M J Sparrer, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial)Susanne Ziefle, Friederike Egberts, Sarah Heinze, et al.Infection|July 10, 2026
Topical trichloroacetic acid versus electrocautery for treatment of anal intraepithelial neoplasia in people living with HIV: a multicentre, randomised, non-inferiority trial (TECAIN-study)Stefan Esser, Alexander Kreuter, Anja Potthoff, et al.The Journal of Antimicrobial Chemotherapy|March 29, 2011
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individualsAlessandro Schipani, Christoph Wyen, Tabitha Mahungu, et al.Pageof 12